Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
29.9M
-
Shares change
-
+14.7M
-
Total reported value, excl. options
-
$20.9M
-
Value change
-
+$9.29M
-
Put/Call ratio
-
2.22
-
Number of buys
-
38
-
Number of sells
-
-35
-
Price
-
$0.70
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q4 2024
97 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q4 2024.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.9M shares
of 92.4M outstanding shares and own 32.37% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (8.92M shares), Caligan Partners LP (7.43M shares), PERCEPTIVE ADVISORS LLC (3.25M shares), BOOTHBAY FUND MANAGEMENT, LLC (2.59M shares), VANGUARD GROUP INC (1.88M shares), BlackRock, Inc. (1.19M shares), STATE STREET CORP (523K shares), GEODE CAPITAL MANAGEMENT, LLC (477K shares), Sovran Advisors, LLC (407K shares), and MORGAN STANLEY (362K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.